Impact of EU label changes for medicinal products containing methotrexate for weekly administration: risk awareness and adherence, A survey study

22/12/2021
27/03/2024
EU PAS number:
EUPAS44827
Study
Finalised
Documents
Study protocol
Initial protocol
English (880.87 KB - PDF) View document
Updated protocol
English (1.27 MB - PDF) View document
Study results
Study results
English (1.69 MB - PDF) View document
Study report
Other information
Study, other information
English (125.49 KB - PDF) View document